The ClinGen Evidence Repository is an FDA-recognized human genetic variant database containing expert-curated assertions regarding variants' pathogenicity and supporting evidence summaries. [Disclaimer]
  • Gene obtained from curated document aligns with the Allele Registry but not with ClinVar data
  • No CSPEC computer assertion could be determined for this classification!


Variant: NM_000133.4(F9):c.720G>A (p.Trp240Ter)

CA414441410

810867 (ClinVar)

Gene: F9
Condition: hemophilia B
Inheritance Mode: X-linked inheritance
UUID: 9da956d4-9ba6-49ac-884f-f34f4a2f4c86
Approved on: 2024-02-09
Published on: 2024-07-11

HGVS expressions

NM_000133.4:c.720G>A
NM_000133.4(F9):c.720G>A (p.Trp240Ter)
NC_000023.11:g.139551261G>A
CM000685.2:g.139551261G>A
NC_000023.10:g.138633420G>A
CM000685.1:g.138633420G>A
NC_000023.9:g.138461086G>A
NG_007994.1:g.25526G>A
ENST00000218099.7:c.720G>A
ENST00000643157.1:n.1387G>A
ENST00000218099.6:c.720G>A
ENST00000394090.2:c.606G>A
NM_000133.3:c.720G>A
NM_001313913.1:c.606G>A
NM_001313913.2:c.606G>A
More

Pathogenic

Met criteria codes 3
PVS1 PM2_Supporting PS4
Not Met criteria codes 1
PP1

Evidence Links 0

Expert Panel

Criteria Specification Information

Criteria Specification: ClinGen Coagulation Factor Deficiency Expert Panel Specifications to the ACMG/AMP Variant Interpretation Guidelines for F9 Version 1.0.0

Criteria Specification Approval History
Criteria Specifications for this VCEP
Evidence submitted by expert panel
Coagulation Factor Deficiency VCEP
The NM_000133.4(F9):c.720G>A variant predicts a nonsense change, Trp240Ter, in exon 6 of the F9 gene; NMD is predicted, meeting PVS1 criteria. The variant is absent from gnomAD v2.1.1 and v3, meeting PM2_Supporting criteria. At least 8 severe hemophilia B patients meeting the F9 phenotype criteria have been reported in the literature (PMIDs: 23093250, 18479429, 8091381, 15086324), meeting PS4_Very strong. Inhibitors to factor replacement therapies have been reported (EAHAD database). In summary, the variant meets criteria to be classified as pathogenic. ACMG/AMP criteria applied, as specified by the Coagulation Factor Deficiency VCEP for F9: PVS1, PS4_Very strong, PM2_Supporting.
Met criteria codes
PVS1
The Trp240Ter variant occurs in exon 6/8 of the F9 gene. NMD is predicted.
PM2_Supporting
The variant is absent from gnomAD v2.1.1 and v3.
PS4
At least 8 severe hemophilia B patients meeting F9 phenotype criteria have been reported in the literature (PMIDs: 23093250, 18479429, 8091381, 15086324) to carry the Trp240Ter variant. Some of the severe patients are noted to have developed inhibitors.
Not Met criteria codes
PP1
2 Irish families (PMID: 18479429) reported with severe hemophilia B and the Trp240Ter variant. Members are male; however information is not available to count the accurate number of meioses to apply PP1.
Curation History
The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. If you have questions about the information contained on this website, please see a health care professional.
¤ Powered by BCM's Genboree.